|
Indian Journal of Human Genetics
Medknow Publications on behalf of Indian Society of Human Genetics
ISSN: 0971-6866 EISSN: 1998-362x
Vol. 12, Num. 1, 2006, pp. 4-10
|
Indian Journal of Human Genetics, Vol. 12, No. 1, January-April, 2006, pp. 4-10
Review Article
Stem cells: A new paradigm
Kumar Sachin, Singh NP
Maulana Azad Medical College and Associated Lok Nayak and G. B. Pant Hospitals, New Delhi - 10002
Correspondence Address:Room No. 27, P.G. Men's Hostel, Maulana Azad
Medical College and Associated Lok Nayak and G. B. Pant Hospitals, New
Delhi - 10002, drkumarsachin@yahoo.com
Code Number: hg06002
Abstract Stem cell therapy is emerging as a potentially revolutionary new way to treat disease and injury, with wide-ranging medical benefits. It aims to repair damaged and diseased body-parts with healthy new cells provided by stem cell transplants. Disease and disorders with no therapies or at best, partially effective ones, are the lure of the pursuit of stem cell research.
Recently a plethora of work has been done in this field in world around including India. However, Stem cell research presents many ethical and scientific questions as well as future challenges.
Nevertheless, stem cell therapy, a prologue to an era of medical discovery of cell-based therapies that will one day restore function to those whose lives are now challenged every day, is still at the beginning of the road.
Keywords: Stem cell, adult stem cell, stem cell therapy.
Introduction
Stem cells are distinctive and versatile type of cells that can divide indefinitely and have a unique capacity to renew themselves and to give rise to specialized cell types. Although most cells of the body, such as heart cells or skin cells, are committed to conduct a specific function, a stem cell is uncommitted and remains uncommitted, until it receives a signal to develop into a specialized cell. Their proliferative capacity combined with the ability to become specialized makes stem cells unique.
Researchers have for years looked for ways to use stem cells to replace
cells and tissues that are damaged or diseased. Recently, stem cells
have received much attention.
In 1998, for the first time, investigators were able to isolate this
class of pluripotent stem cell from early human embryos and grow them
in culture.
In the few years since this discovery, evidence has emerged that these
stem cells are, indeed, capable of becoming almost all of the specialized
cells of the body and, thus, may have the potential to generate replacement
cells for a broad array of tissues and organs, such as the heart, the
pancreas and the nervous system.
Thus, this class of human stem cell holds the promise of being able
to repair or replace cells or tissues that are damaged or destroyed by
many
of our most devastating diseases and disabilities.
What is Stem Cell?
A stem cell is a cell that has the ability to divide (self
replicate) for indefinite periods-often throughout the life
of the organism. Under
the right conditions, or given the right signals, stem cells have the
potential to develop into mature cells that have characteristic shapes
and specialized functions, such as heart cells, skin cells, or nerve
cells[1],[2] [Figure
- 1].
Source of Stem Cells [Figure
- 2]
1) Embryonal stem cell
2) Adult stem cell
Embryonic Stem Cells
As their
name suggests
they are derived
from embryos (blastocyst) that develop from
eggs that have been
fertilized in vitro -in
an in vitro fertilization clinic-and then donated for research
purposes with informed consent of the donors.[3],[4]
Growing embryonic stem cells in the laboratory[5],[6]
Growing cells in the laboratory is known as cell culture. Human embryonic
stem cells are isolated by transferring the inner cell mass into a plastic
laboratory culture dish that contains a nutrient broth known as culture
medium. The cells divide and spread over the surface of the dish. [Figure
- 3]
Over the course of several days, the cells of the inner
cell mass proliferate and begin to crowd the culture dish. When
this occurs,
they
are removed gently and plated into several fresh culture dishes. Embryonic
stem cells that have proliferated in cell culture for six or more months
without differentiating, are pluripotent and appear genetically normal
are referred to as embryonic stem cell line.
Adult Stem Cells
An adult stem cell is an undifferentiated
cell found among differentiated cells in
a tissue or organ, can renew
itself and
can differentiate to
yield the major specialized cell types of the tissue or organ. The primary
roles of adult stem cells in a living organism are to maintain and repair
the tissue in which they are found.
Types of Adult Stem Cells[7],[8]
In the 1960s, researchers discovered
that the bone marrow contains at least
two kinds of stem cells. One population,
called
hematopoietic
stem cells, forms all the types of blood cells in the body. A second
population, called bone marrow stromal cells, was discovered a few years
later. Stromal cells are a mixed cell population that generates bone,
cartilage, fat and fibrous connective tissue.
It was not until the 1990s that scientists agreed
that the adult brain does contain stem cells that are able
to generate
the
brain′s three
major cell types-astrocytes and oligodendrocytes, which are non-neuronal
cells and neurons, or nerve cells.
Sources of Hematopoietic Stem Cells Bone Marrow
The classic source of hematopoietic stem cells (HSCs) is bone marrow.
About 1 in every 100,000 cells in the marrow is a long-term, blood-forming
stem cell; The marrow is aspirated by using a bone aspiration needle under
local anaesthesia.
Peripheral Blood
As a source of HSCs for medical treatments, bone marrow retrieval
directly from bone is quickly fading into history. For clinical transplantation
of human HSCs, doctors now prefer to harvest donor cells from peripheral,
circulating blood.
Researchers have found that they can coax the cells to migrate from
marrow to blood in greater numbers by injecting the donor with a cytokine,
such
as granulocyte-colony stimulating factor (GCSF).
Umbilical Cord Blood Stem Cells
In the late 1980s and early 1990s, physicians began to recognize that
blood from the human umbilical cord and placenta was a rich source of HSCs.
This tissue supports the developing fetus during pregnancy, is delivered
along with the baby and, is usually discarded.
In recent years, however, the multipotent-stem-cell-rich blood found
in the umbilical cord has proven useful in treating the same types of
health
problems as those treated using bone marrow stem cells and PBSCs.
Umbilical cord blood stem cell transplants are less prone to rejection
than either bone marrow or peripheral blood stem cells. This is probably
because the cells have not yet developed the features that can be recognized
and attacked by the recipient′s immune system. Also, because umbilical cord blood lacks well-developed immune cells, there is less chance that the transplanted cells will attack the recipient′s
body, a problem called graft versus host disease.
Both the versatility and availability of umbilical cord blood stem
cells makes them a potent resource for transplant therapies.
Potential uses of Human Stem Cells "Aladdin′s Lamp"
Truly speaking stem cells are no less than "aladdin′s lamp" which
promises to cure most of the diseases that plague the mankind today .
Uses of Hematopoietic Stem Cells ( hscs0 ): Present uses Leukemia and Lymphoma[9],[10]
Among the first clinical uses of HSCs were the treatment of leukemia
and lymphoma, including Hodgkin′s disease, multiple myeloma and non-Hodgkin′s lymphoma. In these applications, the patient′s
own cancerous hematopoietic cells were destroyed via radiation or chemotherapy,
then replaced with a bone marrow transplant, or, as is done now, with a
transplant of HSCs collected from the peripheral circulation of a matched
donor.
Inherited Blood Disorders
Another use of allogeneic bone marrow transplants is in the treatment
of hereditary blood disorders, such as different types of inherited anemia
and inborn errors of metabolism.
The blood disorders include aplastic anemia, beta-thalassemia, Blackfan-Diamond
syndrome, globoid cell leukodystrophy, sickle-cell anemia, severe combined
immunodeficiency, X-linked lymphoproliferative syndrome and Wiskott-Aldrich
syndrome.
Inborn errors of metabolism that are treated with bone marrow transplants
include: Hunter′s syndrome, Hurler′s syndrome, Lesch Nyhan
syndrome and osteopetrosis.
Hematopoietic Stem Cells: Future Prospects Hematopoietic Stem Cell Rescue in cancer Chemotherapy[11]
Chemotherapy aimed at rapidly dividing cancer cells inevitably hits
another target-rapidly dividing hematopoietic cells. Doctors may give cancer
patients an autologous stem cell transplant to replace the cells destroyed
by chemotherapy.
Hematopoietic Stem Cell Therapy for Autoimmune Diseases
The immune-mediated injury in autoimmune diseases can be organ-specific,
such as type 1 diabetes which is the consequence of the destruction of
the pancreatic beta islet cells. These autoimmune diseases are amenable
to treatments involving the repair or replacement of damaged or destroyed
cells or tissue.[12]
In contrast, non-organ-specific autoimmune diseases, such as lupus, are
characterized by widespread injury due to immune reactions against many
different organs and tissues.
The objective of hematopoietic stem cell therapy for lupus is to destroy
the mature, long-lived and autoreactive immune cells and to generate a
new, properly functioning immune system.[13]
Recent reports suggest that this replacement therapy may fundamentally
alter the patient′s immune system. Hence stem cell therapy may hold
a future promise to the treatment of autoimmune disorders.
Stem Cells and Diabetes[14]
For decades, diabetes researchers have been searching for ways to replace
the insulin-producing cells of the pancreas that are destroyed by a patient′s
own immune system.[15] Recently,
hope for a permanent cure of diabetes has appeared, namely, the transplantation
of islets isolated from donor pancreata into the livers of diabetic patients
Some promising results have already been obtained with embryonic stem
cells (ES cells) of both rodent and human origin.[16] However,
the potential use of ES cells for the treatment of diseases in humans is
beclouded in controversy because of the ethical issues.
In theory, embryonic stem cells could be cultivated and coaxed into
developing into the insulin-producing islet cells of the pancreas.
It is concluded that stem cells offer the greatest potential for the
development of an abundant source of pancreatic islets, although specific
obstacles
must be overcome before this can become a reality.[17],[18]
Rebuilding the nervous system with stem cells
The past decade has seen impressive advances in the prevention and
treatment of cerebrovascular disease. Several new therapies are under investigation
to address the long-term disability of stroke survivors. Stem cell therapy
offers exciting potential for ambitious cellular replacement to treat diseases
such as Parkinson′s disease, Alzheimer′s disease or even
replacement of the cell death that follows thromboembolic stroke. Longer-term
safety and efficacy results should enhance our understanding of cell implantation
therapy for the treatment of stroke.
Spinal Cord Disorders[20]
Clinicians and scientists in the field of spinal cord injury research
and medicine are poised to begin translating promising new experimental
findings into treatments for people. Advances in stem cell research have
led to several transplantation strategies that promote axonal regrowth
and partial functional recovery in spinal cord injury. Christopher Reeve
Paralysis Foundation (CRPF) funds research to treat or cure paralysis resulting
from spinal cord injury or other CNS disorders. CPRF supports a Research
Consortium, focus on stem cells, making a lot of progress
Can Stem Cells Repair a Damaged Heart?
For those suffering from common, but deadly, heart diseases, stem
cell biology represents a new medical frontier. Researchers are working
toward using stem cells to replace damaged heart cells and literally restore
cardiac function
Recent interest has focused on myocardial regeneration with stem-cell
transplantation as a possible treatment option to reverse the deleterious
hemodynamic and
neurohormonal effects that occur after myocardial infarction and can lead
to congestive heart failure..
Recently the BOOST trial (Bone marrow transfer to enhance ST-elevation
infarct regeneration) has confirmed an increase in global LVEF by 6.7% in
6 months follow up study.[21] Similar
studies have been conducted recently in India at AIIMS.
Future randomized clinical trials will establish the magnitude of the
benefit and the effects on arrhythmias after stem-cell therapy.[22]
Stem Cell Therapy for HIV[23]
The hematopoietic stem cell has long been hypothesized to be a target
of human immunodeficiency virus type-1 (HIV) infection that limits the
potential for compensatory immune cell production.
Data have recently emerged documenting stem cell dysfunction in HIV
disease and indicating that immune recovery from potent antiretroviral
therapy
is partly driven by new T-cell generation.
Effects of HIV on stem cell physiology, however, appear to be indirect,
as stem cells are highly resistant to HIV infection. Despite the presence
of surface receptors for HIV, the hematopoietic stem cell is not infectible
with HIV and can serve as a resource for cellular therapies for AIDS.
Orthopaedics
It is now possible to repair articular cartilage using the patient′s
own articular chondrocytes retrieved during arthroscopy and expanded in vitro .
Pulmonary medicine: cystic fibrosis, idiopathic pulmonary fibrosis,
lung transplantation are the recent areas of pursuit. Ophthalmology : Stem cells hold promise to retinal degeneration,
glaucoma and corneal disorders.
Pitfalls of Stem Cell Research
Stem cell research has been the centre of debate of recent times.
Unfortunately, the medical application of stem cell technology is caught
in a web of ethical dilemmas that is compounded by grave technical hurdles.
There are several important issues which impinge on the future of stem
cell research, which are not only of a scientific or technical nature,
but are related to ethical and moral issues on the use of human embryonic
or adult cells.
Ethical Dilemmas
To use an embryo as a source of body cells is a very different notion
both scientifically and ethically. It treats the embryo purely functionally
as a "ball of cells", as a resource and no longer as a whole. The notion
that it is okay to destroy embryos because they were created for research
in the first place is wrong. This is playing the role of God!
Two Biological Hurdles to Stem Cell Therapy
Any stem cell therapy will have to clear two hurdles.
Immune Rejection[24]
The first hurdle to clear is immune rejection. Patients receiving a
graft of embryonic stem cells or adult stem cells sourced from unrelated
donors would probably be treated in much the same way that organ transplant
recipients are treated. The grafts would be matched to the individual patient
and anti-rejection drugs would be used. If patients provide their own stem
cells, then of course immune rejection is no problem. Leukaemia patients
routinely rely on their own stem cells. After cancer therapy, which destroys
stem cells, patients rely on the stored stem cells to rapidly restore their
red and white blood cell counts to normal.
Long Term Sequelae and Neoplastic Potential[25]
Any stem cell, adult or embryonic, has the ammunition it needs to
give rise to cancer: an explosive ability to grow and to change into other
types of cells. In fact, researchers now realize that at the heart of many
common cancers lies an adult stem cell gone awry.
Any stem cell lines injected into patients have to be carefully tested
first in animals to see if they give rise to cancer. Lymphoproliferative
disease may occur during the first year, leukemia and myelodysplastic syndromes
develop after several years, whereas solid tumors occur even later as long
term sequelae.
Though cautious, researchers believe they will be able to tame the
tendency of stem cells to form cancers.
Stem Cell- Indian Perspective
A lost science?
In Adi parva, one of the chapters of Mahabharata, it is said that Kauravas
were created from pinda [a ball of flesh] which Gandhari delivered after
two years of pregnancy. It was then handed over to the sage Dwapayan, which
was then divided into one hundred parts and treated with herbs and ghee.
The pieces were then covered with cloth and kept in a chamber to cool for
two years; out of which the Kauravas were born." There cannot be any other
explanation for this.."[26].
The ancient sages of India must have perfected the art of regenerating
entire human beings from cells. In fact Mahabharata clearly describes the
various stages of processing pieces of flesh, which is in fact closely
comparable to modern techniques of harvesting and processing embryonic
stem cells.[sans the sophistication!]. Perhaps stem cell research was altogether
a lost science of ancient India.
The Rediscovery
By choice, chance or by coincidence, India too is into stem cell research.
India has emerged as one of the major countries involved in Stem cell research.
A country which succeeded in becoming an IT superpower is also trying to
replicate its success in stem cell research. Apart from the pride and prestige
earned by researchers in the country, the researches in stem cell technology
are adding more horsepower to the booming economy of the country. Stem
cell research in India made it to the headlines when the US department
of health disclosed its interest in funding stem cell research in two Indian
centres.
1) Reliance Life Sciences [RLS]
The Reliance life Sciences[RLS]; backed by the industry major Reliance
Ltd ranks third among the top-10 institutes worldwide working on stem cells,
as stated by NIH of the US and that too came just when the RLS was just
8months old! The center is headed by Dr Firuza Parikh, the creator of the
first ICSI [Intra Cytoplasmic Sperm Injection] child in India.
2) National Centre for Biological Sciences [NCBS]
The National center for biological sciences had been working on stem
cells for quite long.[since 1999] and has three documented stem cell lines.
3) The Maulana Azad Medical College, Delhi is another major institution
involved in stem cell research; and studies here are led by Dr Balakrishna
Matapurkar, one of the pioneers of stem cell research in India.[27]
4) Another major institute involved in stem cell research in India is the
L. V. Prasad Eye Institute, based at Hyderabad. The Institute caught the
headlines recently when its doctors succeeded in transplanting a stem cell
derived cornea to a patient who had lost his cornea- a treatment option
available only in the US at that time.
The Indian Stem Cell Boom
Recently the Ruby Hall Medical Research Centre, a subsidiary of Pune-based
Ruby Hall Clinic and Denmark-based biotechnology company Mesibo are soon
to form a 49:51 joint venture with an aim to establish India′s largest
cord blood storage facility at Pune. These measures got a pat on the back
when NIH announced its interest in funding research in stem cells in the
country. Recently contribution from the Indian researchers in the field
of stem cell therapy have been recognized worldwide.[28],[29]
Ethics: The Indian Perspective
When ethical jingoism dominated the scenario in the west, eastern
countries like India and Singapore were taking rapid strides to reap the
benefits of this science to the maximum possible extent.
Unlike the public opinion in the west, which is against researches
in this field, the public opinion in many eastern countries including
India is
far more supportive. This may be partly due to the scientific temper inculcated
by the epics and in numerous religious texts which are in fact acclaimed
worldwide for their scientific value.
This openness is reflected in the Indian Department of Biotechnology
[DBT]′s
statement that India is open to stem Cell research; and it promptly made
regulatory provisions to control unethical practices and in fact pioneered
in bringing up a widely acceptable legal framework for research.
Indian Council of Medical Research
Guidelines for stem cell research/regulation in India (Oct. 2000)
Realising the potentials of this new technology in modern therapeutics
and biomedical research it is strongly recommended that Stem cell research
and its clinical applications should be promoted in the country. The guidelines provides basis and recommendations for the stem cell
research in India.
Take Home Message
Stem cells are distinctive and versatile type of cells. Stem cells can divide indefinitely in culture and produce many types
of new cells.
Pluripotent stem cells can produce most body cells .
Stem cell research provides the opportunity to advance our understanding
of human biology and treatment of various diseases.
Stem cell research presents ethical and scientific questions
as well as future challenges, Stem cell research is still
at the beginning
of the
road .
References
1. | Chandross KJ, Mezey E. Plasticity of adult bone marrow stem cells. Mattson MP and Van Zant G editors. JAI Press: Greenwich, CT; 2001. Back to cited text no. 1 |
2. | Slack JM. Stem cells in epithelial tissues. Science 2000;287:1431-3. Back to cited text no. 2 [PUBMED] [FULLTEXT] |
3. | Bain G, Kitchens D, Yao M, Huettner JE, Gottlieb DI. Embryonic stem cells express neuronal properties. Dev Biol 1995;168:342-57. Back to cited text no. 3 [PUBMED] [FULLTEXT] |
4. | Odorico JS, Kaufman DS, Thomson JA. Multilineage differentiation from human embryonic stem cell lines. Stem Cells 2001;19:193-204. Back to cited text no. 4 [PUBMED] [FULLTEXT] |
5. | Potocnik AJ, Nielsen PJ, Eichmann K. In vitrogeneration of lymphoid precursors from embryonic stem cells. EMBO J 1994;13:5274-83. Back to cited text no. 5 [PUBMED] [FULLTEXT] |
6. | Akashi K, Traver D, Kondo M, Weissman IL. Lymphoid development from hematopoietic stem cells. Int J Hematol 1999;69:217-26. Back to cited text no. 6 [PUBMED] |
7. | Franco locatelli, hoemopoetic stem cell transplantation. 2004;125:3-11. Back to cited text no. 7 |
8. | Morshead CM, van der Kooy KD. A new 'spin' on neural stem cells? Curr Opin Neurobiol 2001;11:59-65. Back to cited text no. 8 |
9. | Cutler C, Antin JH. Peripheral blood stem cells for allogeneic transplantation: a review. Stem Cells 2001;19:108-17. Back to cited text no. 9 |
10. | Ema H, Takano H, Sudo K. In vitro self renewal division of hematopoietic stem cells. J Exp Med 2000;192:1281-8. Back to cited text no. 10 |
11. | Joshi SS, Tarantolo SR, Kessinger A. Antitumor therapeutic potential of activated human umbilical cord blood cells against leukemia and breast cancer. Clin Cancer Res 2000;6:4351-8. Back to cited text no. 11 |
12. | Grossman JM, Tsao BP. Genetics and systemic lupus erythematosus. Curr Rheumatol Rep 2000;2:13-8. Back to cited text no. 12 |
13. | Harley CB, Gearhart J, Jaenisch R, Rossant J, Thomson J. Keystone Symposia. Pluripotent stem cells: biology and applications. Durango, CO; 2001. Back to cited text no. 13 |
14. | Yamada S, Terada K, Ueno Y, Sugiyama T, Seno M, Kojima I. Differentiation of adult hepatic stem-like cells into pancreatic endocrine cells. Cell Transplant 2005;14:647-53. Back to cited text no. 14 |
15. | Casu A, Trucco M, Pietropaolo M. A look to the future: prediction, prevention and cure including islet transplantation and stem cell therapy. Pediatr Clin North Am 2005;52:1779-804. Back to cited text no. 15 |
16. | Lechner A, Habener JF. Stem/progenitor cells derived from adult tissues: potential for the treatment of diabetes mellitus. Am J Physiol Endocrinol Metab 2003;284:259-66. Back to cited text no. 16 |
17. | Street CN, Rajotte RV, Korbutt GS. Stem cells: a promising source of pancreatic islets for transplantation in type 1 diabetes. Curr Top Dev Biol 2003;58:111-36. Back to cited text no. 17 |
18. | Islet Cell Transplant for Type 1 Diabetes Successful Across Multiple Centers. American Diabetes Association June 6, 2004. 64th Annual Scientific Sessions. Back to cited text no. 18 |
19. | Ostenfeld T, Svendsen CN. Recent advances in stem cell neurobiology. Adv Tech Stand Neurosurg 2003;28:3-89. Back to cited text no. 19 |
20. | Okano H, Okada S, Nakamura M. Neural stem cells and regeneration of injured spinal cord. Kidney Int 2005;68:1927-31. Back to cited text no. 20 |
21. | W0 ollaret KC . 0 BOOST trial (Bone marrow transfer to enhance ST-elevation infarct). Lancet 2004;364. Back to cited text no. 21 |
22. | Mathur A, Martin JF. Stem cells and repair of the heart. Lancet 2004;364:183-92. Back to cited text no. 22 |
23. | Monogr. Stem cell and HIV infection. J Natl Cancer Inst 2000;28:24-9. Back to cited text no. 23 |
24. | Priddle H, Jones DR, Burridge PW. Hematopoiesis from Human Embryonic Stem Cells: Overcoming the Immune Barrier in Stem Cell Therapies. Stem Cells 2005;23. Back to cited text no. 24 |
25. | Bjerkvig R, Tysnes BB, Aboody KS. Opinion: the origin of the cancer stem cell:current controversies and new insights. Nat Rev Cancer 2005;5:899-904. Back to cited text no. 25 |
26. | Matapurkar BG, Bhargave A, Dawson L, Sonal B. Organogenesis by desired metaplasia of autogenous stem cells. Arch Surg 1998;857:263-7. Back to cited text no. 26 |
27. | Matapurkar BG, Bhargave A, Dawson L, Sonal B. Organogenesis by desired metaplasia of autogenous stem cells Ann NY Acad Sci 1998;857:263-7. Back to cited text no. 27 |
28. | Joshi D, Behari M. Neuronal stem cells. Neuro J India 2003:51:323-8. Back to cited text no. 28 |
29. | Ramakrishnan S, Kothari SS, Bahl VK. Stem Cells and Myocardial Regeneration. Indian Heart J 2003;55:119-24. Back to cited text no. 29 |
Copyright 2006 - Indian Journal of Human Genetics
The following images related to this document are available:
Photo images
[hg06002f2.jpg]
[hg06002f1.jpg]
[hg06002f3.jpg]
|